Literature DB >> 23940278

Ubiquitin-specific protease 13 regulates IFN signaling by stabilizing STAT1.

Hom-Ming Yeh1, Chia-Yi Yu, Ho-Chun Yang, Shih-Han Ko, Ching-Len Liao, Yi-Ling Lin.   

Abstract

The IFN immune system comprises type I, II, and III IFNs, signals through the JAK-STAT pathway, and plays central roles in host defense against viral infection. Posttranslational modifications such as ubiquitination regulate diverse molecules in the IFN pathway. To search for the deubiquitinating enzymes (DUBs) involved in the antiviral activity of IFN, we used RNA interference screening to identify a human DUB, ubiquitin-specific protease (USP) 13, whose expression modulates the antiviral activity of IFN-α against dengue virus serotype 2 (DEN-2). The signaling events and anti-DEN-2 activities of IFN-α and IFN-γ were reduced in cells with USP13 knockdown but enhanced with USP13 overexpression. USP13 may regulate STAT1 protein because the protein level and stability of STAT1 were increased with USP13 overexpression. Furthermore, STAT1 ubiquitination was reduced in cells with USP13 overexpression and increased with USP13 knockdown regardless of with or without IFN-α treatment. Thus, USP13 positively regulates type I and type II IFN signaling by deubiquitinating and stabilizing STAT1 protein. Overall, to our knowledge, USP13 is the first DUB identified to modulate STAT1 and play a role in the antiviral activity of IFN against DEN-2 replication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23940278     DOI: 10.4049/jimmunol.1300225

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Systems biology unravels interferon responses to respiratory virus infections.

Authors:  Andrea L Kroeker; Kevin M Coombs
Journal:  World J Biol Chem       Date:  2014-02-26

2.  USP13 controls the stability of Aurora B impacting progression through the cell cycle.

Authors:  Mara Esposito; H Begum Akman; Philippe Giron; M Angeles Ceregido; Rogier Schepers; Luis C Ramos Paez; Esther La Monaca; Jacques De Greve; Olivier Coux; Carl De Trez; Catherine Lindon; Gustavo J Gutierrez
Journal:  Oncogene       Date:  2020-08-08       Impact factor: 9.867

Review 3.  Deubiquitylating enzymes: potential target in autoimmune diseases.

Authors:  Niraj Parihar; Lokesh Kumar Bhatt
Journal:  Inflammopharmacology       Date:  2021-11-18       Impact factor: 4.473

Review 4.  Ubiquitin Ligases and Deubiquitinating Enzymes in CD4+ T Cell Effector Fate Choice and Function.

Authors:  Awo A K Layman; Paula M Oliver
Journal:  J Immunol       Date:  2016-05-15       Impact factor: 5.422

Review 5.  Long noncoding RNAs in viral infections.

Authors:  Puri Fortes; Kevin V Morris
Journal:  Virus Res       Date:  2015-10-23       Impact factor: 3.303

6.  USP13 regulates the replication stress response by deubiquitinating TopBP1.

Authors:  Wootae Kim; Fei Zhao; Huanyao Gao; Sisi Qin; Jing Hou; Min Deng; Jake A Kloeber; Jinzhou Huang; Qin Zhou; Guijie Guo; Ming Gao; Xiangyu Zeng; Shouhai Zhu; Xinyi Tu; Zheming Wu; Yong Zhang; Ping Yin; Scott H Kaufmann; Kuntian Luo; Zhenkun Lou
Journal:  DNA Repair (Amst)       Date:  2021-02-06

7.  Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics.

Authors:  Zhengyun Liu; Yan Xu; Wanling Zhang; Xinghong Gao; Guo Luo; Hong Song; Jie Liu; Huan Wang
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

8.  USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis.

Authors:  Min Li; Yanqin Xu; Jie Liang; Hao Lin; Xinyue Qi; Fanlin Li; Ping Han; Yanfeng Gao; Xuanming Yang
Journal:  Mol Ther       Date:  2021-02-15       Impact factor: 12.910

Review 9.  Deubiquitinases in cancer.

Authors:  Rongbin Wei; Xiaodong Liu; Weixin Yu; Tianshu Yang; Wenping Cai; Junjun Liu; Xiao Huang; Guo-tong Xu; Shouliang Zhao; Jianhua Yang; Shangfeng Liu
Journal:  Oncotarget       Date:  2015-05-30

10.  G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA.

Authors:  Katell Bidet; Dhivya Dadlani; Mariano A Garcia-Blanco
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.